Autobio Diagnostics Co Ltd (603658)

Shanghai

Currency in CNY

40.16

-0.44(-1.08%)

Closed08:59:59

Fair Value

Day's Range

39.96

40.48

52 wk Range

37.56

66.36

603658 Income Statement

Featured here, the Income Statement (earnings report) for Autobio Diagnostics Co Ltd, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2014

31/12

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

Total Revenues

2,679.44

2,978.13

3,765.92

4,441.63

4,443.66

Total Revenues Growth

+38.85%

+11.15%

+26.45%

+17.94%

+0.05%

Cost Of Revenues

911.39

1,216.04

1,544.58

1,844.47

1,611.8

Gross Profit

1,768.05

1,762.09

2,221.34

2,597.16

2,831.86

Gross Profit Growth

+39.19%

-0.34%

+26.06%

+16.92%

+9.04%

Gross Profit Margin %

65.99%

59.17%

58.99%

58.47%

63.73%

Other Operating Expenses, Total

903.04

981.61

1,267.06

1,470.92

1,625.59

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+41.02%	+8.7%	+29.08%	+16.09%	+10.51%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	311.91	342.8	480.96	568.48	656.13
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	564.36	616.06	772.37	874.21	941.4
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	26.77	22.75	13.73	28.24	28.05

Operating Income

865.01

780.48

954.28

1,126.24

1,206.27

Operating Income Growth

+37.32%

-9.77%

+22.27%

+18.02%

+7.11%

EBIT Margin %

32.28%

26.21%

25.34%

25.36%

27.15%

Net Interest Expenses

-6.09

32.75

103.74

113.86

120.22

Net Interest Expenses Growth

-171.54%

+637.95%

+216.74%

+9.75%

+5.59%

Interest Expense, Total

-23.72

-29.05

-12.68

-21.23

-24.54

Interest And Investment Income

17.63

61.8

116.43

135.09

144.76

Other Non Operating Expenses, Total

-2.89

-18.54

-8.88

2.29

-0.67

EBT, Excl. Unusual Items

856.03

794.69

1,049.14

1,242.38

1,325.83

Gain (Loss) On Sale Of Assets

-5.48

-1.13

-1.17

-1.72

-2.78

Other Unusual Items, Total

35.91

50.88

17.54

53.06

38.92

EBT, Incl. Unusual Items

885.74

844.53

1,065.55

1,293.71

1,362.54

EBT, Incl. Unusual Items Growth

+35.32%

-4.65%

+26.17%

+21.41%

+5.32%

EBT, Incl. Unusual Items Margin

33.06%

28.36%

28.29%

29.13%

30.66%

Income Tax Expense

98.84

87.44

85.69

105.03

138.41

Net Income to Company

786.9

757.09

979.86

1,188.68

1,224.13

Minority Interest

-12.74

-9.3

-6.19

-21.25

-6.69

Net Income

774.16

747.79

973.66

1,167.44

1,217.44

Net Income Growth

+37.61%

-3.41%

+30.2%

+19.9%

+4.28%

Net Income Margin %

28.89%

25.11%

25.85%

26.28%

27.4%

Preferred Dividend and Other Adjustments

-

-

-

-

-

Net Income to Common Excl. Extra Items

774.16

747.79

973.66

1,167.44

1,217.44

Basic EPS - Continuing Operations

1.42

1.34

1.66

2

2.1

Basic EPS - Continuing Operations Growth

+37.31%

-5.33%

+23.88%

+20.48%

+5%

Diluted EPS - Continuing Operations

1.42

1.34

1.66

2

2.1

Diluted EPS - Continuing Operations Growth

+37.31%

-5.33%

+23.88%

+20.48%

+5%

Basic Weighted Average Shares Outstanding

546.96

558.06

586.54

583.72

579.73

Diluted Weighted Average Shares Outstanding

546.96

558.06

586.54

583.72

579.73

Dividend Per Share

0.69

0.65

0.75

0.8

1.05

Dividend Per Share Growth

+12.5%

-5.56%

+14.71%

+6.67%

+31.51%

EBITDA

1,082.71

1,082.04

1,340.21

1,543.8

1,642.37

EBITDA Growth

+36.2%

-0.06%

+23.86%

+15.19%

+6.39%

EBITDA Margin %

40.41%

36.33%

35.59%

34.76%

36.96%

EBIT